Zobrazeno 1 - 10
of 101
pro vyhledávání: '"J A Schifferli"'
Autor:
J A Schifferli, Manuel Battegay, Salima Sadallah, Luregn J. Schlapbach, Thomas Klimkait, Christoph Schaefer, Verena Werder, Christoph Hess, Eliska Horakova, Veronika Del Zenero, Gianmarco M. Balestra
Publikováno v:
The Lancet. 359:2230-2234
Treatment of HIV-1-infected individuals with antiretrovirals can result in sustained suppression of plasma viral RNA at concentrations below the detection limit of available assays. However, continuing virus replication has been detected in patients
Publikováno v:
Blood. 96:2822-2827
Antibodies against myeloperoxidase (MPO) and proteinase 3 (PR3) are the predominant autoantibodies present in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Their binding to the corresponding antigen on the surface of polymorphonuc
Autor:
M. Trendelenburg, J. A. Schifferli
Publikováno v:
Zeitschrift f�r Rheumatologie. 59:172-175
Eine Fehlregulation der Apoptose ruckt immer mehr in den Vordergrund der Erklarungsversuche von Autoimmunvorgangen beim Systemischen Lupus Erythematodes (SLE). Ein defekter Mechanismus der Clearance von apoptotischen Zellen oder ungewohnlich hohe Apo
Autor:
Sybille Schwarz, Olivier Spertini, Salima Sadallah, Alois Gratwohl, Estelle Lach, J A Schifferli
Publikováno v:
Journal of Leukocyte Biology. 65:94-101
Complement receptor type 1 is expressed by erythrocytes and most leukocytes. A soluble form is shed from the leukocytes and found in plasma (sCR1). sCR1 is a powerful inhibitor of complement. We report an increased sCR1 in the plasma of leukemia pati
Autor:
M Stahl, J A Schifferli
Publikováno v:
Nephrology Dialysis Transplantation. 13:2182-2185
Publikováno v:
Hepatology. 24:118-122
Complement receptor type 1 (CR1) is an integral membrane protein of many hematopoietic cells and is found in a soluble form in plasma. Preliminary data have indicated that soluble complement receptor 1 (sCR1) levels in serum were increased in patient
Autor:
Philippe Morel, G. Grau, Shaoping Deng, Leo Buhler, J A Schifferli, Jinning Lou, H P Wessel, Manuel Pascual
Publikováno v:
Transplantation. 61:1300-1305
Binding of recipient natural antibodies to the endothelium of the graft, complement activation, endothelial cell activation, and microvascular thrombosis are major events in the hyperacute rejection of organ xenografts. The aim of this study was to i
Autor:
J A Schifferli, M A E Buylaert
Publikováno v:
Therapeutische Umschau. 61:725-727
Eine seltene Nebenwirkung von nicht-steroidalen-Antirheumatika (NSAR) ist die akute allergische interstitielle Nephritis (ISN). Diese Reaktion beruht auf einer allergisch-immunologischen Reaktion im Niereninterstitium mit Tubulusschädigung, wobei es
Autor:
Marten Trendelenburg, J A Schifferli
Publikováno v:
Clinical and Experimental Immunology. 133:153-155
Soon after the discovery of hepatitis C virus (HCV) by Choo and colleagues [1] and the establishment of serological tests [2] for the detection of antibodies against HCV (anti-HCV) it became apparent that ‘mixed essential cryoglobulinaemia’ was,
Publikováno v:
The Journal of Experimental Medicine
Complement receptor 1 (CR1) is present on erythrocytes (E-CR1), various leucocytes, and renal glomerular epithelial cells (podocytes). In addition, plasma contains a soluble form of CR1 (sCR1). By using a specific ELISA, CR1 was detected in the urine